China Feihe Limited (Ticker: CHFLF) is a leading producer of infant formula milk powder and other dairy products in China, specializing in premium formula made from proprietary Feihe milk sources. The company offers a comprehensive portfolio of products including infant and young child formula milk powders under the Feihe brand, such as Feiyi, Feiqiong, and Feihong series; adult milk powders; liquid milk products; and goat milk formulas, all emphasizing high-quality, traceable domestic milk from its integrated supply chain in Heilongjiang province. Feihe operates primarily in the consumer staples sector, targeting mothers, families, and health-conscious adults across China with a focus on nutritional dairy solutions backed by scientific research and innovation.
Founded in 1962 and headquartered in Beijing, China, the company maintains extensive geographic operations within China, including manufacturing facilities, dairy farms, and distribution networks spanning key regions. Feihe sources fresh milk exclusively from its own pastures and partner farms in northern China, ensuring product purity and compliance with stringent safety standards. It serves as a standalone listed entity on the Hong Kong Stock Exchange since 2015, with no major parent company relationships noted.
In recent developments, China Feihe expanded its product offerings with new launches including upgraded organic infant formulas and advanced nutritional supplements in 2024, responding to evolving consumer demands for immunity-boosting and cognitive health products. The company secured strategic partnerships with leading pediatric research institutions for clinical validations and invested in supply chain enhancements, including new high-tech dairy farms to boost production capacity amid rising domestic demand. Additionally, Feihe announced a significant share repurchase program in late 2024 and reported robust revenue growth in its 2025 interim results, driven by market share gains in the premium infant formula segment.